CA
NZ
UK
AU
IND
US
● Seer is a life-sciences technology company whose Proteograph Product Suite is designed to enable large-scale, deep proteomic analysis, helping researchers study proteins across large sample sets.
Once a prominent name in genomic medicine, Sangamo Therapeutics, Inc (OTC: SGMOQ) is now a company in wind-down, and its stock reflects it. Trading around 16 cents on the over-the-counter market and carrying the 'Q' suffix that signals bankruptcy proceedings, the shares are no …
Shuttle Pharmaceuticals Holdings, Inc (NASDAQ:SHPH) has undergone one of the more startling identity shifts on the Nasdaq this year. A company that listed as a radiation-oncology drug developer spent 2026 reinventing itself aroundCryptocurrencymining, and it now carries a fresh Nasdaq compliance problem on top …
Few names capture the peculiarEconomicsof biodefense quite like SIGA Technologies Inc (NASDAQ: SIGA). The company sells a single flagship antiviral to governments stockpiling against smallpox and related orthopoxviruses, which makes itsRevenuefamously lumpy and its share price sensitive to procurement timing. After a softer trading …
● Retractable Technologies has long positioned itself as a scrappy American manufacturer in a global market dominated by far larger rivals.
● Few names capture the promise and the peril of computational drug discovery as sharply as Recursion Pharmaceuticals.
Rockwell Medical, Inc (NASDAQ:RMTI) has spent 2026 reshaping itself, and the market is still deciding how to price the result. After a reverse stock split, a restored Nasdaq listing standing and a revenue base in transition, shares of the dialysis-products supplier have drifted modestly …
A quoted 99% drop looks catastrophic until you notice the arithmetic behind it. Redwood Scientific Technologies, Inc. (OTC:RSCI) trades in ten-thousandths of a dollar, a realm where a move from just over a penny to the $0.0001 minimum tick registers as a near-total wipeout …
The Q appended to RVLPQ tells much of the story. RVL Pharmaceuticals plc (OTC:RVLPQ), the specialty-pharma company behind Upneeq, an eyedrop for droopy eyelids, now trades at a fraction of a cent under a ticker whose suffix conventionally signals bankruptcy or severe distress.
Few diagnostics stocks have had a rougher stretch than QuidelOrtho Corporation (NASDAQ:QDEL). Once a pandemic-era testing darling, the company has watched its shares slide from a 52-week high near $35.58 to around $12.64, and a recent daily drop keeps the pressure squarely on management's …
Please wait processing your request...